Rest of the World — Net revenue
ResMed Rest of the World — Net revenue remained flat by 0.0% to $465.19M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.1%, from $426.31M to $465.19M. Over 4 years (FY 2021 to FY 2025), Rest of the World — Net revenue shows an upward trend with a 10.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful international market penetration and growing demand for products in non-domestic regions, while a decrease may signal competitive pressure or regulatory hurdles in those markets.
Detailed definition
This metric represents the total revenue generated from sales of medical devices, masks, and accessories within geograph...
Peer comparison
Comparable to 'International Revenue' or 'Revenue by Geography' reported by other global medical device manufacturers.
rmd_segment_rest_of_the_world_net_revenueHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.23B | $1.33B | $1.50B | $1.71B | $1.86B |
| YoY Change | — | +7.7% | +13.1% | +13.5% | +9.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is ResMed's rest of the world — net revenue?
- ResMed (RMD) reported rest of the world — net revenue of $465.19M in Q2 2025.
- How has ResMed's rest of the world — net revenue changed year-over-year?
- ResMed's rest of the world — net revenue increased by 9.1% year-over-year, from $426.31M to $465.19M.
- What is the long-term trend for ResMed's rest of the world — net revenue?
- Over 4 years (2021 to 2025), ResMed's rest of the world — net revenue has grown at a 10.8% compound annual growth rate (CAGR), from $1.23B to $1.86B.
- What does rest of the world — net revenue mean?
- Total sales revenue earned from all geographic regions excluding the company's primary home market.